Ignite Creation Date:
2024-05-05 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00150657
Status:
UNKNOWN
Last Update Posted:
2005-11-29
First Post:
2005-09-06
Brief Title:
Study of CarboplatinGemcitabine Plus Bevacizumab in Advanced Lung Cancer
Sponsor:
St John Providence Health System
Organization:
St John Providence Health System
Organization Data
Organization:
St John Providence Health System
Class:
OTHER
Study ID:
AVF3121s
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
St John Providence Health System
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Eli Lilly and Company | INDUSTRY |
| Genentech Inc | INDUSTRY |